Daily as of 2 Nov 16:00 ET
- Price
- between the two $366.16 vs 50 $374.53 / 200 $313.63
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 28 Jul 2026 · projected 26 bars out
BIO | Bio-Rad Laboratories, Inc.Class ANYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$366.16
-$6.02 (-1.62%)
Bio-Rad Laboratories, Inc.Class A (BIO) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits above the 50 and the 200; on the daily it is between the two. On the weekly a golden cross is projected within 10 bars.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $372.18 vs 50 $312.04 / 200 $326.71
- Projection
- 🟨Golden cross projected in 8 bars
- Test
- No active test
- Last cross
- 💀Death cross week of 26 Dec 2022 · projected 27 bars out · tested 3 bars
4-hour as of 3 Nov 16:00 ET
- Price
- above both $374.91 vs 50 $367.79 / 200 $345.98
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 10 Jun 2026 bar 2 · projected 24 bars out · tested 1 bar
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 28 Jul 2026 | 🟨Golden steep | daily | 26 bars out | Not tested |
| 10 Jun 2026 | 🟨Golden | 4-hour | 24 bars out | 1 bar cross test |
| 24 Mar 2026 | 💀Death steep | daily | 23 bars out | 2 bar cross test |
| 10 Feb 2026 | 💀Death | 4-hour | 23 bars out | Not tested |
| 23 Sep 2025 | 🟨Golden moderate | daily | 29 bars out | 4 bar cross test |
About BIO
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$91.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge